Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nasdaq Global Funds, Inc. was a subsidiary of Nasdaq, Inc. (formerly The Nasdaq Stock Market, Inc.) that served as the sponsor for various exchange-traded funds (ETFs), most notably the Nasdaq-100 Trust (QQQ). Founded in 1998 as Nasdaq Financial Products Services, Inc., the company was responsible for the creation and management of investment products tracking Nasdaq indices. In 2007, Nasdaq transferred the sponsorship of its ETF business, including the QQQ, to PowerShares (now Invesco), effectively exiting the direct fund sponsorship business. While the company was a major player in the financial markets, it is not a biotechnology or healthcare company, although it sponsored funds that included many biotech firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nasdaq Global Funds.